01.13.21

EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 Vaccine

Source: FirstWord

11.30.20

UK Government Asks Regulator to Clear “Temporary Supply” of AstraZeneca’s COVID-19 Vaccine

Source: FirstWord

11.23.20

AstraZeneca Says COVID-19 Vaccine Candidate Shows 70% Efficacy

Source: FirstWord

11.20.20

Data Confirm Immune Response From AstraZeneca’s COVID-19 Vaccine in Elderly

Source: FirstWord

11.13.20

AstraZeneca’s Calquence Fails to Help Patients Hospitalized With COVID-19 Respiratory Symptoms

Source: FirstWord

10.27.20

AstraZeneca’s COVID-19 Vaccine Produces Robust Immune Response in Elderly

Source: FirstWord

10.26.20

AstraZeneca, J&J Say Their COVID-19 Vaccine Trials Back on Track in US

Source: FirstWord

10.22.20

Suspected Control Group Participant in AstraZeneca COVID-19 Vaccine Study Dies; Trial Continues

Source: FirstWord

10.21.20

Sources Say US Study of AstraZeneca’s COVID-19 Vaccine May Restart This Week

Source: FirstWord

10.12.20

AstraZeneca to Test Long-Acting Antibody Treatment AZD7442 in COVID-19 Trials

Source: FirstWord

View more stories